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 SUMMARY 
 
Chilean Salmon Farming is an important industry nowadays in Chile with significant economics 
entry to the country. The troubles with the handling and maintenance of this industry to avoid 
product losses is a key factor of concern right now. Piscirickettsiosis disease has been a problem 
that persist over the time in this industry and several attempts had been made to try to solve the 
mortalities induced by this fish pathogen. According to Aquaculture and Fishery report from 
Sernapesca, the amount of harvest Chilean Atlantic salmon was around 152.806 tons in 2014 
and represent around USD$ 1,292 million. During the year 2014, the main cause of mortalities 
is Piscirickettsiosis, affecting all three salmonid species farmed in Chile, reaching 74% in Atlantic 
salmon, 73% in rainbow trout and 36% in coho salmon. The lack of effective treatments to 
control Piscirickettsiosis has emphasized the need to develop techniques for diseases prevention. 
Management of the disease is based on several husbandry practices including the application of 
immunostimulants of unproven efficacy and the control of vertical transmission by an expensive 
selection procedure during reproduction. Piscirickettsia salmonis is the causative agent for 
Piscirickettsiosis diseases that affects the three salmonid species farming in Chile. Currently, our 
knowledge about this pathogen is limited to a few articles that described the induction of 
apoptosis in phagocytic host cells, the presence of the type 4B secretion system at transcript 
level, the possible evasion of the phagocytic pathway after internalization in the host cell, the 
increased gene expression levels of two virulence factors with a key role in the intracellular 
survival (ClpB and BipA), and recently the enclosed genome for the LF-89 strain.  
The results found in this work, could provide a real evidence how the bacteria can establish the 
infection inside the host cell, using the Type 4B Secretion System to translocate effector proteins 
that subvert the vesicle trafficking to its own benefits. Showing the presence at protein level of 
this secretion system, could generate the possibility to use new antigens to develop new vaccines 
against this pathogen to control the disease and lower the mortality induced by P. salmonis.  
 
 
 
 
 
 RESUMEN 
 
La Salmonicultura chilena es una industria importante hoy en día en el país con un ingreso 
económico significativo. Los problemas con el manejo y mantenimiento de este sector para 
evitar pérdidas de producto por enfermedades es un factor clave de preocupación en este 
momento. La enfermedad Piscirickettsiosis ha sido un problema que persiste en el tiempo en 
esta industria y se han realizado varios intentos para tratar de resolver las mortalidades inducidas 
por este agente patógeno de peces. Según informe de Sernapesca, la cantidad de cosecha de 
salmón Atlántico chileno fue de alrededor de 152.806 toneladas en 2014 y representan alrededor 
de USD $ 1.292 millones. Durante el año 2014, la principal causa de mortalidad es 
Piscirickettsiosis, que afectó a las tres especies de salmónidos cultivados en Chile, alcanzando el 
74% en el salmón del Atlántico, el 73% en la trucha arco iris y el 36% en el salmón Coho. La 
falta de tratamientos efectivos para controlar la Piscirickettsiosis ha hecho hincapié en la 
necesidad de desarrollar técnicas para la prevención de enfermedades. El manejo de la 
enfermedad se basa en varias prácticas durante el cultivo, incluyendo la aplicación de 
inmunoestimulantes de eficacia no comprobada y el control de la transmisión vertical por un 
procedimiento de selección caro durante la reproducción. Piscirickettsia salmonis es el agente 
causante de la enfermedad Piscirickettsiosis que afecta a las tres especies de salmónidos 
cultivados en Chile. Actualmente, nuestro conocimiento acerca de este patógeno se limita a unos 
pocos artículos que describen la inducción de apoptosis en células huésped fagocítica, la 
presencia del sistema de secreción de tipo 4B a nivel génico, la posible evasión de la vía fagocítica 
después de la internalización en la célula huésped, altos niveles de expresión de genes de dos 
factores de virulencia con un papel clave en la supervivencia intracelular (ClpB y BIPA), y 
recientemente el genoma cerrado para la cepa tipo LF-89. Los resultados encontrados en este 
trabajo, proporcionan evidencia real de como este patógeno puede establecer la infección dentro 
de la célula huésped, mediante el Sistema de Secreción Tipo 4B para traslocar proteínas efectoras 
(SdhA) que subvierten el tráfico vesicular para su propio beneficio. Demostrando la presencia a 
nivel proteico de este sistema de secreción se podrían generar vacunas contra este patógeno, 
utilizando estos nuevos antígenos para controlar la enfermedad y reducir la mortalidad generada 
por P. salmonis. 
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1. INTRODUCTION. 
 
1.1 CHILEAN SALMON FARMING 
 
The beginnings of salmon farming in Chile are dated on the year 1850 when foreign investors 
and the Fisheries Development Institute (IFOP) introduced exotic aquatic species; the first 
Coho salmon was imported to Chile in 1921. In 1974 began the commercial Rainbow trout 
farming and also the exportation, which triggered a radical shift to salmon farming in Chile. In 
1978 the Chilean government contribution was the establishment of the Fisheries Department 
and the National Fisheries Service (Servicio Nacional de Pesca y Acuicultura, SERNAPESCA), and 
between 1978 and 1980 several private initiatives lead to the foundation of exclusively salmon 
farming companies. In 1990 the first Coho salmon was cultivated. This step represents the first 
scientific advancement regarding fish industries in Chile and triggered the real takeoff for 
salmon farming. Together with the improvement of feeding techniques, the industry began to 
use better farming processes to improve the rearing of salmon. In 2003 the industry developed 
a Code of Good Practice but in 2007 the first case of Infectious Salmon Anemia (ISA) was 
reported. This disease caused important economics losses to the industry and a rapid setting up 
of a public-private partnership was required to solve this problem. Currently, the three 
salmonid species cultures in Chile are Atlantic salmon, the most commercial species, reaching a 
weight to 4,5- 5 kgs when harvested; Pacific salmon which takes 10 to 12 months to harvest 
with almost 3 kgs of weight; and Rainbow trout which also is harvested around 3 kgs taking 10 
to 12 months to reach this weight (salmonchile.cl). According to Aquaculture and Fishery 
report from Sernapesca (2014), the amount of harvested Chilean Atlantic salmon was around 
152.806 tons in 2014 and represent around USD$ 1,292 million (fig. 1). During the year 2014, 
the main cause of mortalities is Piscirickettsiosis, affecting all three salmonid species farmed in 
Chile, reaching 74% in Atlantic salmon, 73% in Rainbow trout and 36% in Coho salmon (fig. 
2) (Sanitary report from Sernapesca 2014/February 2015). 
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Total export in aquaculture sector until May from 2013 to 2014 
 Export Value (mUSD$) Quantity (tons) 
Resource 2013 2014 2013 2014 
Atlantic salmon 826.676 1.292.661 127.524 152.806 
Coho salmon 253.983 378.435 76.287 62.318 
Rainbow trout 334.587 322.496 58.290 32.567 
 
   
 
Figure 1: Harvest amount (tons) and economics export (USD$) of three salmonid species 
cultured in Chile during 2013- 2014 (Sernapesca 2014). 
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1.2 PATHOGENS AND DISEASE IN CHILEAN SALMON FARMING 
 
Aquaculture is nowadays an emerging and very productive industry in Chile, specifically, 
salmon farming. With the increased development of the industry, the outcome of several 
diseases is inevitable. Handling and good practice are the key factors to avoid the beginning 
and dissemination of the diseases. 
There are many microorganisms that induce several diseases in salmonid species. For viral 
infection there are two main viruses inducing diseases in salmonid fishes: the Infectious 
Pancreatic Necrosis Virus (IPNV) and Infectious Salmon Anemia Virus (ISAV). The ISAV 
induced a significant economic loses in 2007 spreading among several companies of salmon 
farming in Chile. Currently there are other kinds of viral infection in Chilean salmon farming 
but not with the severity of ISAV but still its needed to be considered (Crane and Hyatt, 2011). 
For Gram positive bacterial infection, among others, there are Bacterial Kidney Disease 
(BKD) induced by Renibacterium salmoninarum, Furunculosis induced mainly by Flavobacterium 
salmoninarum, Streptococcosis induced by Streptococcus phocae and Mycobacteriosis induced by 
Mycobacterium marinum. For Gram negative bacterial infection there are Vibriosis induced mainly 
by Vibrio anguillarum, winter ulcer induced by Moritella viscosa, Photobacteriosis (pasteurellosis) 
induced by Photobacterium damselae subsp. piscicida, Furunculosis induced by Aeromonas salmonicida, 
Edwardsiellosis induced by Edwardsiella tarda, enteric redmouth induced by Yersinia ruckeri and 
Piscirickettsiosis induced by the intracellular pathogen Piscirickettsia salmonis (Toranzo et al., 
2005; Sudheesh et al., 2012). Piscirickettsia salmonis is the intracellular bacterium that causes 
Salmonid Rickettsial Syndrome (SRS) or Piscirickettsiosis, an infectious disease that kills 
millions of farmed fish each year. Piscirickettsiosis is a serious threat to the global salmon 
aquaculture industry (Rise, et al., 2004). 
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Figure 2: accumulative mortalities induced by infectious diseases affecting the three salmonid 
species farmed in Chile, according to sanitary report from Sernapesca 2014. Piscirickettsiosis is 
the main cause of mortalities in Atlantic salmon and Rainbow trout. 
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1.2.1 PISCIRICKETTSIOSIS AND Piscirickettsia salmonis 
 
Piscirickettsiosis (fig. 3) is a systemic disease that shows external clinical signs as pale gills from 
significant anemia, fin ulcerations, abdominal swelling, petechial and ecchymotic hemorrhages 
on the base of fins and in the perianal zones. Also, the fish behavior change when they are 
severely affected with this disease, showing dark skin color, inappetence, lethargy and swim 
near to the surface or edges of cages. Internal clinical signs typical are swollen kidney, liver and 
spleen due to the systemically spread of the bacterium. Also it is observed petechial 
hemorrhages in visceral organs, swim bladder wall and skeletal muscle, and also the presence 
of caverns inside the muscle as a clear area or with exudates. (Rozas and Enriquez, 2014). 
Piscirickettsiosis occurs during saltwater stage of the salmonid life cycle, and is horizontally 
transmitted (Gaggero et al., 1995). The etiological agent that causes this disease is Piscirickettsia 
salmonis characterized as a Gram-negative, intracellular facultative bacterium. It is described as 
pleomorphic, predominantly coccoid in shape, pairs grouped, ranging in diameter between 0.5 
to 1.5 µm (fig. 4), and it has been present for a long time and apparently since the Salmon 
farming industry begun in Chile. It was first described in the year 1989 when the bacterium 
was considered to be a Rickettsia species and classified as an obligate intracellular 
microorganism. Currently we know that this bacterium can grow in absence of cells in 
specialized medium. Indeed, Yáñez et al. (2012) described a specific medium in which the 
bacteria can grow perfectly in a range between 15 to 18 °C. This bacterium, isolated in 1989 
from moribund Coho salmon from saltwater net pen site in the south of Chile, was the first 
Rickettsia-like organism (RLO) recognized as a fish pathogen (Fryer et al., 1990). The 
Piscirickettsiaceae family currently contains five genera, Piscirickettsia, Cycloclasticus, Hydrogenovibrio, 
Methylophaga and Thiomicrospira, that are phylogenetically related but they have a few phenotypic 
characteristics in common and the only member of the Piscirickettsia genus is Piscirickettsia 
salmonis (Fryer and Hedrick, 2003). Molecular phylogenetic analysis based on sequencing the 
16S rRNA gene, placed Piscirickettsia salmonis in the new family of Piscirickettsiaceae within the 
class of γ- proteobacteria, most closely related to Coxiella, Francisella and Legionella (Fryer et al., 
1992; Rozas and Enriquez, 2014). 
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Figure 3: external (A) and internal (B) clinical signs of Piscirickettsiosis disease affecting 
salmonid species. (Rozas and Enriquez, 2014). In panel A it’s observed petechial and 
ecchymotic hemorrhages in fins (a), raised scales (b), multiple and diffuse hemorrhagic skin 
ulcers (c) and focal skin ulcers. In panel B it is observed serosanguinous ascites, splenomegaly, 
pale liver and diffuse petechial hemorrhages (a – b), hyperaemia and diffuse hemorrhages and 
pethechiae in the encephalon (c) and caverns inside the skeletal muscle (d). 
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Figure 4: Gram staining, Transmission Electron Microscopy and IFAT images of Piscirickettsia 
salmonis. 
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The lack of effective treatments to control Piscirickettsiosis has emphasized the need to 
develop techniques for diseases prevention. Management of the disease is based on several 
husbandry practices including the application of immunostimulants of unproven efficacy and 
the control of vertical transmission by an expensive selection procedure during reproduction 
(Wilhelm et al., 2006). Although vaccines made of inactivated bacteria have been successfully 
used to control certain bacterial disease in fish (Gudding et al., 1999); preparations based on P. 
salmonis bacteria have not yielded significant protection against Piscirickettsiosis (Smith et al., 
1997; Kuzyk et al., 2001). P. salmonis infections are septicemic and initially target monocytes 
followed by infection of the endothelium of the kidney, liver, spleen, heart, brain, intestine, 
ovary and gills of salmonids (Cvitanich et al., 1991). The mechanisms used by this bacterium to 
survive and replicate inside the host cells are still poorly understood. 
 
1.3 PATHOGENESIS AND VIRULENCE FACTORS 
 
Phagocytosis is responsible for the internalization of microorganisms, damaged cells, and inert 
particles. Some intracellular pathogens inhabit vacuoles that interact with compartments of the 
biosynthetic pathway, while others escape from the phagocytosis or remain in vacuoles which 
neither acidify nor fuse with lysosomes (Berón et al., 2002). The acid environment appears to 
be essential for Coxiella burnetti replication since raising the lysosomal pH with lysosomotropic 
amines or proton pump V-ATPase inhibitors reduces the growth of C. burnetti (Hackstadt and 
Williams, 1981; Heinzen et al., 1996). Howe and Mallavia (2000) have shown, in an in vitro 
assay, increased protein synthesis in Coxiella burnetti incubated at pH 5.5 (endosomal pH) 
compared to that observed at pH 4.5 (lysosomal pH). Since C. burnetti replicates only when it is 
phagocytosed and transported to the phagolysosome, dissecting this transport pathway at the 
molecular level will help us to find a therapeutic approach for this infectious agent (Berón et al., 
2002). Many bacterial pathogens use Secretion Systems as part of their infection machinery to 
establish the infection inside the host cells. Protein secretion across membranes is a key aspect 
in bacterial virulence and occurs through a variety of mechanisms, from a simple one-
component system to complex multi-component machineries.  
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The two main mechanisms used by pathogens to delivery substrates to the extracellular milieu 
or cytoplasm, are known as direct and indirect pathways. The indirect pathway is used for 
toxins without cell contact and the direct pathway for effector proteins that is cell contact 
dependent. Both have similar function which is to manipulate the environment so the bacteria 
can establish the infection and replicate. The macromolecules delivered are referred to as 
effectors because they affect and alter host cellular processes, resulting in the spread of the 
disease (Backert and Meyer, 2006). All these molecules described in pathogenicity from 
bacterial infection are denominated as virulence factor because the bacteria use them to invade 
the organism/host and continuing their life cycle. 
 
1.3.1 PROTEIN SECRETION SYSTEMS 
 
Currently there are several protein Secretion Systems described in prokaryotes. The secretion 
of the E. coli hemolysin is an excellent model of Type 1 Secretion System (T1SS). T1SS is 
comprised of three components: HlyB, HlyD and TolC. HlyB is an ABC transporter in the 
inner membrane which is a homodimer; HlyD is a trimeric inner membrane protein with a 
large periplasmic domain which contacts the outer membrane component TolC in the 
presence of the substrate HlyA. The Type 2 Secretion System (T2SS) also known as the 
General Secretion Pathway (GSP) is the major secretion pathway in Gram-negative bacteria. 
The best studied T2SS is from Klebsiella oxytoca. The components of T2SS are named Gsp to 
unify names between bacteria. This kind of Secretion System works together with the Sec 
pathway to export proteins outside the cell. In the T2SS, the secreted proteins are folded in the 
periplasm prior to secretion (Dalbey and Kuhn, 2012). To this T2SS belongs the Sec pathway, 
the sec genes named secA, B, D, E, F, G and Y, which are involved in the export of proteins 
across the E. coli inner membrane. This Sec-dependent pathway works with two complexes 
inserted in the inner membrane, SecYEG and SecDF-YajC. It’s proposed that the SecYEG 
translocon is the main complex working in this type of secretion, exporting the substrates, and 
the SecDF-YajC complex helps with the insertion and de-insertion of the SecA protein 
(cycling) to maintain the Proton-Motive Force (PMF) (Duong and Wickner, 1997). It’s 
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described also that this Sec-dependent pathway can work together with the Type 1, 4 and 5 
Secretion Systems, depending on the environmental conditions (Dalbey and Kuhn, 2012). 
One of the most studied systems is the Type 3 Secretion System (T3SS) used by bacterial 
pathogens such as Salmonella enterica and Shigella flexneri, (Cornelis and Van Gijsegem, 2000). 
This Type 3 Secretion System (T3SS) is found in pathogenic and symbiotic bacteria that infect 
both animal and plant cells. The substrates from T3SS are named effector proteins and they 
are exported out of the cell in a 1-step process. This Secretion System involves more than 25 
proteins that are highly conserved among the pathogenic bacterial species and several show 
sequence similarities with flagellar assembly genes. The Type 4 Secretion System (T4SS) is 
observed in both Gram-negative and Gram-positive bacteria. The evolutionary origin of the 
system is the conjugational system and it is employed for the transport of virulence proteins 
and DNA into eukaryotic cells, as well as for the conjugative transfer of plasmids from one 
bacterium to another. The T4SS of Agrobacterium tumefaciens is typical for this system and is 
employed to transfer a specific part of the tumor-inducing Ti-plasmid into a plant cell. This is 
called VirB/D System or also named Type 4A Secretion System (Dalbey and Kuhn, 2012). 
There also exists another kind of T4SS studied in Legionella pneumophila, named Dot/Icm or 
Type 4B Secretion System (Vogel, et al., 1998; Segal, et al., 1998). The Type 5 Secretion System 
(T5SS) includes autotransporters and 2-partner systems; one of the partners is the Sec-
dependent pathway (Dalbey and Kuhn, 2012). The Type 6 Secretion System (T6SS) exists in 
most Proteobacteria that come into close contact with eukaryotic cells. The genetic clusters, 
which contain as few as 12 to more than 20 genes, are usually found in pathogenicity islands, 
and the gene expression is upregulated on contact with the host cell (Mougous et al., 2007). It 
is possible that the T6SS has evolved from a bacteriophage and allows bacteria to use the tip of 
the T6SS needle to deliver the respective T6SS proteins with enzymatic activity into the host 
cell (Dalbey and Kuhn, 2012). The Type 7 Secretion System (T7SS), also termed ESX, is 
present in Mycobacterium tuberculosis which shows a highly unusual and complex cell envelope, so 
it uses specialized protein secretion system to secrete virulence factors. Mycobacterial genomes 
contain up to five genetic loci coding for T7SS, named ESX-1 to ESX-5 (Daleke, et al., 2011). 
Finally, the Type 9 Secretion System or Por Secretion System involves the porK, porL, porM, 
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porN, porP, porQ, porT, porU, porV, porW and sov gene products (Sato, et al., 2010; McBride and 
Zhu, 2013). Recently, it has been described that Piscirickettsia salmonis possess the Type 4B 
Secretion System which increased the gene expression levels of specific genes belonging to this 
T4BSS. 
 
1.3.2 TYPE 4 SECRETION SYSTEM AND EFFECTOR PROTEINS 
 
Many bacteria, such as Agrobacterium tumefaciens, Helicobacter pylori, Bordetella pertussis, Brucella sp., 
Legionella pneumophila, Coxiella burnetii and others, utilize functionally homologues systems 
known as Type 4 Secretion System (T4SS) for pathogenesis. T4SS are bacterial devices 
homologous to conjugation systems that are used by bacteria to deliver macromolecules 
(nucleoprotein complexes and proteins) across kingdom barriers (Christie and Vogel, 2000). 
The T4SS was divided into two subgroups: systems that resemble the A. tumefacines Vir system 
and the pKM101 Tra system were named Type 4A, and systems that resemble the L. 
pneumophila Icm/Dot System and the IncI plasmids Tra/Trb System were named Type 4B 
(Christie and Vogel, 2000). Up to date, two bacterial pathogens, L. pneumophila and C. burnetii, 
were shown containing a type 4B Secretion System (fig. 5), which was shown to be essential 
for L. pneumophila pathogenesis (Vogel, et al., 1998), and recent information suggests that this is 
also the case for C. burnetii (Zamboni,  et al., 2003). 
Gram-negative L. pneumophila is an environmental pathogen which normally replicates within a 
protozoan host. This intracellular facultative bacterium is an opportunistic human pathogen, 
and it causes the Legionnaires’ disease. The disease is associated with efficient replication of L. 
pneumophila inside monocytes and alveolar macrophages with the latter being the primary site of 
bacterial growth. Internalized L. pneumophila forms a distinct Legionella-containing vacuole 
(LCV). Bacterial pathogens use a broad range of effectors to subvert and control normal 
cellular functions. Effectors are usually specialized proteins that are injected directly into the 
cytosol of the host cell by Type 3 Secretion System (T3SS) or a Type 4 Secretion System 
(T4SS). These secretion systems consist of a structurally conserved proteinaceous apparatus 
that is shaped like a needle (Galan and Wolf-Hatz, 2006). 
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Most of our current knowledge on this intracellular survival strategy comes from research on 
Legionella pneumophila. A functional T4BSS, encoded by a group of 24 genes called dot/icm (fig. 
5), is essential for the protein secretion process (Segal, et al., 1998; Vogel, et al., 1998).  
The distribution of these proteins from outer space to cytoplasm are present in a different 
manner among bacteria. Studies made in Legionella and Coxiella give us the possible orientation 
and localization of all these proteins and several protein complexes were identified. One of 
them is formed by DotH, DotG, DotF, DotC and DotD that joint the inner and outer 
membrane and is the functionally core complex. Another complex is formed by DotL, DotM 
and DotN that work as an ATPase for the secretion system. Also were found a few proteins in 
the periplasmic space like IcmX (free in periplasmic space) and DotK (inserted in outer 
membrane, periplasmic side); there are several proteins inserted in the inner membrane like 
DotU, IcmF, DotJ, DotV, DotE, IcmT, DotI, IcmV, DotP and DotA (ATPase), and some 
cytoplasmic proteins also like DotB, that work as ATPase. Also was found the chaperone 
subcomplexe IcmS/IcmW (fig. 5) (van Schaik et al., 2013). 
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Figure 5: proposed model for distribution and localization of T4BSS proteins in Legionella 
pneumophila and Coxiella burnetii (van Schaik, et al., 2013). 
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Transport of these effector molecules results in the biochemical manipulation of the host cell 
processes, promoting a favorable replicative niche for the bacterium and its survival. 
Pathogens such as L. pneumophila contain T4SS genes (dot/icm) that are associated with the 
establishment of a replication-permissive phagosome in eukaryotic hosts after phagocytosis 
(Chien et al., 2004). 
Although regulated assembly of these specialized Secretion Systems is often coordinated tightly 
with the expression of their cognate secretion substrates, common recognition elements must 
exist to not only promote transport by the correct pathway, but also to serve as a control 
mechanism for choosing only a particular set of proteins for transport among a pool of 
cytoplasmic candidates (Cambronne and Roy, 2006). First identified from genes called “defect 
organelle trafficking” (dot) and “intracellular multiplication” (icm) that were required for 
replication of the pathogen L. pneumophila in eukaryotic host cells, the Type 4B transport 
system now has been identified also in Coxiella and Xanthomonas species (Seshadri, et al., 2003; 
Thieme, et al., 2005).  
Many Dot/Icm substrate proteins have homology to eukaryotic proteins, and the sequencing 
of several L. pneumophila strains has revealed extensive genomic plasticity which affects the 
number of copies and the diversity of Dot/Icm substrates found in the genome (Cazalet et al., 
2004). T3SS substrate recognition is mediated by signals located in the N-termini of effector 
proteins, whereas the T4SS recognizes an element in the C-termini (Cambronne and Roy, 
2006). Legionella pneumophila and Coxiella burnetii are evolutionary closely related bacteria that 
belong to the Gamma-proteobacteria (Weisburg et al., 1989). 
Gómez et al. (2013) described the presence of dotG and dotH genes during infectious process 
induced by Piscirickettsia salmonis on CHSE-214 cell line after 48 hours post infection. Recently, 
Isla et al. (2014) demonstrated the presence of the clpB and bipA genes at transcript levels in an 
infection induced by Piscirickettsia salmonis in the SHK-1 cell line. Those genes are important 
during infectious process as effector proteins with unknown function in Piscirickettsia salmonis. 
Currently, our knowledge about this bacterium is limited to a few articles that describe the 
induction of apoptosis in phagocytic host cells (Rojas, et al., 2010), the presence of the type 4B 
secretion system at transcript level (Gómez, et al., 2013), the possible evasion of the phagocytic 
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pathway after internalization in the host cell (Gómez, et al., 2013), the increase of gene 
expression levels of two virulence factors with a key role in the intracellular survival (ClpB and 
BipA) (Isla A, et al., 2014), and recently the complete genome for the LF-89 strain (Pulgar et al., 
2015). With the exception of the information mentioned above, all other knowledge comes 
from the study of the related pathogens L. pneumophila and C. burnetii, both 
Gammaproteobacteria like P. salmonis. 
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1.4 HYPOTHESIS AND OBJECTIVES 
 
Using all this information above and some preliminary results I propose the Hypothesis: 
 
“The effector protein SdhA and Secretion System Type 4B (Dot/Icm) from 
Piscirickettsia salmonis are involved in the bacterial pathogenicity during in vitro 
infection” 
 
General Objective: 
 
 To Assess the expression and function of dotG, dotH and sdhA genes from Secretion System 
type 4B (Dot/Icm) in Piscirickettsia salmonis during in vitro infection. 
 
Specific Objectives 
 
 To determine the mRNA levels of dotG, dotH and sdhA genes from Secretion System type 4B 
in P. salmonis during in vitro infection. 
 To analyze the presence at protein levels of DotG, DotH and SdhA from Secretion System 
type 4b during in vitro infection induced by P. salmonis. 
 To determine the role of SdhA during in vitro infection by blocking its translation with 
Antisense Oligonucleotide (ASO). 
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2. MATERIALS AND METHODS 
 
2.1 MATERIALS 
 
2.1.1 CHEMICAL REAGENTS 
 
The following reagents were used during the research work: 
 
Amresco: N,N,N´,N´-tetrametiletilendiamine (TEMED), Sodium Bicarbonate (NaHCO3). 
AppliChem: acrylamide/bis-acrylamide (N,N´-metilenbisacrilamide). 
Biological Industries: bovine serum albumin (BSA), trypsin-EDTA. 
CalbioChem: glycine, glycerol. 
Fermentas Life Sciences: pageruler plus prestained protein ladder. 
Gibco: fetal bovine serum (FBS), Leibovitz´s medium L-15. 
Hyclone (ThermoScientific): antibiotic solution (10 U/mL penicillin G, 10 µg/mL 
streptomycin, 25 µg/mL amphotericin B), goat anti-chicken HRP conjugated antibody, Pierce 
ECL Western Blotting Substrate. 
IDTDNA Technologies: oligonucleotides for molecular biology (Real Time RT-PCR), oligo 
dT (15- 27bp). 
Maestrogen: accuruler RGB prestained protein ladder. 
Merck: hydrochloric acid (HCl); glacial acetic acid (CH3COOH); ethanol (CH3CH2OH), 
sodium hydroxide (NaOH); tris (hydroxymethyl) aminomethano (H2NC(CH2OH)3); potassium 
chloride (KCl); Triton X-100; Coomassie blue R-250 (C45H44N3NaO7S2); ammonium persulfate 
((NH4)2S208); Tween®20; bromophenol blue; β-mercaptoethanol, sulfuric acid 95-97% 
(H2SO4). 
Metabion: oligonucleotides for molecular biology (Real Time RT-PCR) and antisense 
oligonucleotides phosphorothioate (ASO). 
Promega: Random Primers, M-MLV Reverse Transcriptase, RNasin. 
SantaCruz Biotechnologies: EEA-1, Rab7, LAMP-1 antibodies. 
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Sigma Chemical Co: Tittermax gold adjuvant, Freund’s adjuvant Complete and Incomplete. 
Sigma-Aldrich: TMB 3,3,5,5-tetramethylbenzidine. 
USBiological: sodium dihydrogen phosphate monohydrate (Na2HPO4H20); sodium hydrogen 
phosphate (NaH2PO4); sodium dodecyl sulfate (SDS), anhydride monobasic potassium 
phosphate (KH2PO4). 
Winkler: sodium chloride (NaCl); 2- propanol (CH3CH(OH)CH3), Nonidet P40 
((C2H4O)nC14H22O), lab grade Ethanol, lab grade Methanol, 2-Propanol, Chloroform, Ether. 
 
2.1.2 BUFFERS AND SOLUTIONS 
 
PBS 1X: 100 mL of PBS 10X (NaCl 0.138M; KCl 0.0027M; Na2HPO4 0.01M, pH 7.4) and fill 
with distilled water to 1L. 
TBS 1X: 100 mL of TBS 10X (NaCl 0.15M; Tris 0.01M pH 8.0) and fill with distilled water to 
1L. 
TAE 1X: 20 mL of TAE 50X (2M Tris, 50mM EDTA pH 8.0) and fill with distilled water to 
1L. 
RIPA buffer: Tris-HCl 50mM; NaCl 150mM; NP-40 1%; sodium deoxycholate 0.5%; SDS 
1% at pH 7.5. 
Upper buffer: Tris-HCl 0.5M, pH 6.8. 
Lower buffer Tris-HCl 1.5M, pH 8.8. 
Loading buffer: Tris-HCl 62.5 mM; SDS 2%; glycerol 10%; β-mercaptoethanol 10%; 
bromophenol blue 0.01% a pH 6.8. 
Running buffer: Tris 0.1M; glycine 0.768M, SDS 0.4%. 
Blotting buffer: Tris 25M, glycine 193mM, methanol 20%. 
Tris-HCl buffer: Tris 0.0625M at pH 6.8. 
Western blot blocking solution: powder milk 10% (p/v) in PBS 1X. 
Fix solution SDS-PAGE: 2-propanol 25%, acetic acid 10%. 
Staining SDS-PAGE: Coomasie blue R-250 0.3%; methanol 50%; acetic acid 10%. 
De-staining solution SDS-PAGE: acetic acid 7%, methanol 30%. 
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Silver staining solution: Fix buffer (50% Methanol; 10% Acetic Acid); Wash buffer 1 (50% 
Ethanol); Wash buffer 2 (10% Ethanol); Blocking buffer (0.2% (w/v) Na2S2O3 in H2O); 
Staining buffer (0.1% AgNO3, Formaldehyde stock); Develop buffer (6% (w/v) Na2CO3, 
Formaldehyde stock); Stop buffer (10% Acetic Acid) 
Washing solution western blot: Tween-20 0.1% (v/v) in TBS 1X. 
Antibody solution: NaCl 0.25M 14.61g/L; NaH2PO4 2.9mM 0.4g/L; Na2HPO4 7.1mM 1.008 
g/L; BSA 1500 mg/L a pH 7.6. 
Dialysis solution: NaCl 0.25M 14.61g/L; NaH2PO4 2.9mM 0,4g/L; Na2HPO4 7.1mM 1.008 
g/L, pH 7.6. 
 
2.1.3 EQUIPMENTS 
 
Stirring magnetic Nuova (Stirrer), orbital stirring Polymax 1040 (Heidolph), analytic weight 
AS310/C/2 (Radwag), Balanza granataria, WTB 3000 (Radwag), thermoregµlatory bath 
(Memmert), laminar flow chamber NU425-400E (Nuaire), centrifuge model 5702 (Eppendorf), 
refrigerator centrifuge high speed CR 22GIII-R20A2 (Hitachi), power supply Power Pac HC 
(Bio-Rad), Biosafety Cabinet Class 2 (Esco), homogenizer Silent Crusher M (Heidolph), orbital 
shaker incubator LM-510-2/5 (mcr), incubator FOC 2251 (VELP Scientifica), dialysis 
membrane Spectra/Por MWCO: 25,000 (Spectrum),  Polyvinylidene difluoride membrane 
(PVDF) (ThermoScientific), Micropipettes P2, P10, P20, P200, P1000, P5000 (Axygen), optical 
microscope DM 2500 (Leica), inverted microscope CKX41 (Olympus), pH-meter Orion 3 Star 
Plus pH Benchtop Meter (ThermoScientific), electrophoresis system Mini-Protean Tetra 
System (Bio-Rad), blotting system Mini trans-blot cell (Bio-Rad), Sonicator µltrasonic Liquid 
Processors XL-2000 series (Misonix), Vortex Mixer VM-2000 (mcr), Eppendorf Mµltiporator 
(Bacteria Modµl 4308 805.005). 
 
2.1.4 ANIMAL MODEL 
 
Hens Lohmann strain: Adult hens of about 6-8 weeks of age were used, which were provided by the 
nursery of the Institute of Animal Pathology, Faculty of Veterinary Sciences, Universidad Austral de 
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Chile and were kept under daily regime of 12h light/dark with a water-based food (commercial pellet) 
"ad libitum" according to current regulations of biosecurity measures from "Manual of Standards for 
Biosafety" CONICYT 1994. Once the hens were immunized diet remained the same way until the end 
of the collection of eggs. 
Rats Sprague Dawley: young rats since 1 month of life (100g of weight) were kept under controlled 
condition by the authorized personnel. When the rats had around 150g of weight they were inoculated 
with at least three injections of synthetic peptides during 6 weeks in total, with a waiting time between 
injections of two weeks. At the end of the inoculation, all the blood from all the rats was collected and 
the serum extracted to get the polyclonal antibodies for the subsequent experiments. 
 
2.1.5 CELL LINE AND BACTERIAL STRAIN 
 
SHK-1: adherent cell line from kidney head of Atlantic salmon. To maintain the cell line, Leibovitz’s 
medium L-15 supplied with 10% of FBS and 1X of antibiotic mix was used. The cells were grown in 
T25 or T75 flask at 18°C without CO2 and with periodic medium changes every 5 days. When the cells 
were confluent, cells were detached from the bottom using 3 ml of trypsin with PBS 1X (1:1), 
centrifuged at 2000xg for 5 minutes and the cells resuspended from the pellet in fresh L-15 medium 
with FBS and antibiotic. The day before initiate the infection experiments, the cells were washed three 
times with PBS 1X and added to L-15 medium with 2% of FBS without antibiotic and kept in this 
conditions during the whole experiment. 
AUSTRAL-005: this strain was isolated from Rainbow trout diagnosed with Piscirickettsiosis. 
It was kindly provided by BIOVAC S.A. This bacterium was used for the growing assays in 
medium AUSTRAL-SRS broth, protein extracts, RNA extracts and for the infection 
experiments in eukaryotic cells.  
LF-89: this strain ATCC VR-1361 was used to compare the cytopathic effect on eukaryotic 
cells. 
All the infection experiments were carried out using MOI 10, with incubation times termed 
short times (0h, 2h, 4h, 8h, 16h, 24h) and long times (2d, 4d, 6d, 8d). 
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2.2. METHODS 
 
2.2.1 BACTERIAL CULTURE IN LIQUID MEDIUM 
 
The bacterium P. salmonis was cultured in liquid medium AUSTRAL-SRS Broth (Yáñez et al., 
2012). This medium is based on marine medium, supplied with peptone and yeast extract as 
nitrogen source. Furthermore, it is supplied with FBS, salts, aminoacid and glucose. Doing 
measurements of absorbance at 600nm, it is possible to determine the exponential growing 
stage in culture from the third day reaching the stationary stage at sixth day of culture. To 
perform the experiments, the bacteria were always cultured at 18°C with 150 rpm of shaking 
during five days. After this time, to confirm the purity of the culture, the Gram staining was 
performed. Also the PCR analysis with specific primers was done to confirm the purity of the 
bacterial culture. Once the exponential stage was reached, the bacteria were collected by 
centrifugation at 3500xg to proceed with the experiments or protein extract. 
 
2.2.2 Piscirickettsia salmonis GRAM STAINING 
 
Approximately 10µL of bacteria growing in liquid medium AUSTRAL-SRS Broth, were put onto a 
slide. After dried, sample was covered first with the primary reactive (crystal violet) for one minute. 
After that, the sample was washed with distilled water and then the second reactive was used (lugol) 
and again incubated for one minute. Then, the slide was washed again with distilled water. Now, it was 
time for the third reactive (acetone/alcohol) to decolorize the sample for a few seconds (3-10 seconds). 
Finally, the last reactive (safranin) was used to counterstain the sample during 30-60 seconds. After this 
time, the slide was washed with distilled water, the sample dried and the staining reaction checked 
under the optical microscope using immersion oil (100X). 
 
2.2.3 PCR AND REAL TIME PCR 
 
From each infection experiment, RNA was extracted by using 1000µL of Trizol Reagent (Ambion) for 
each sample and then mixed with 200µL Chloroform solution, vortexed for 15 seconds and centrifuged 
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20 minutes at 12000xg at 4°C. The upper soluble supernatant was recovered in a new tube (near 300µL) 
and mixed with 500µL of 2-Propanol and incubated at -20°C overnight. Next day, the total RNA 
extraction was carried out by commercial (Axygen) Total RNA extraction kit. The nucleic acid was 
quantified with Nanodrop Maestrogen Equipment. To ensure no contamination with DNA, 5µg of 
total RNA from all samples were treated with DNase Epicenter at final volume of 50µL incubated at 
37°C for 10 minutes. For the cDNA 1µg of total RNA from each sample was used and the Reverse 
Transcription (M-MLV Promega) reaction was carried out by manufacturer’s protocol. Briefly, 1µg of 
RNA from each sample at first step was mixed with 1nM of Random Primers and oligo dT mix (oligo 
dT from 15 to 27 bp) and incubated at 70°C for 5 minutes. After this step, the RNA/primer was mixed 
with the secondary solution (5µL RT buffer 5X, 1.25µL dNTPs 10mM, 0.75µL RNaseOUT 40U/µL) 
and adjusted with Nuclease Free water to 25µL of final volume. The RNA mixed solution was 
incubated 60 minutes at 37°C. The PCR and Real Time PCR were carried out with the same thermal 
profile as follows: initial denaturation at 95°C for 5 minutes; denaturation in the cycle at 95°C for 15 
seconds; annealing at 60°C for 15 seconds; extension in the cycle at 72°C for 15 seconds; final 
extension at 72°C for 5 minutes. For Real Time PCR, after the extension step in the cycle, the melting 
curve from 55°C to 95°C was determined to evaluate the specificity of the primers. For PCR 35 cycles 
and for Real Time PCR 40 cycles were used. For all the conventional PCR reaction GoTaq Flexi 2X 
(Promega) and for Real Time PCR SYBR-Green 2X kit (Axygen) were used. 1µL of cDNA from each 
sample was used in a conventional PCR machine for Real Time PCRs. The primers used for each 
detection are described in table 1. As normalizing gene 23S, from P. salmonis strain AUSTRAL-005 was 
used and as a calibrator for Relative Quantification, it was used the 0 hour post infection in all infection 
experiments. To confirm the purity of the bacterial culture, the same 23S primers proven with samples 
from E. coli and Francisella noatunensis showing not amplification signal, were used. 
 
2.2.4 BCA PROTEIN QUANTIFICATION 
 
To get the total protein extract from the bacteria, the bacterial pellet was collected by centrifugation of 
the liquid medium AUSTRAL-SRS broth; after resuspension in 500µL RIPA buffer (Tris-HCl 50mM; 
NaCl 150mM; NP-40 1%; sodium deoxycholate 0,5%; SDS 1%; pH 7,5) with PMSF 1X, and 
incubation on ice for 20 minutes, cells were sonicated at 80 Watts for 2 minutes with pulses every 20 
seconds. Centrifugation at 16000xg for 20 minutes at 4°C collected the proteins in the supernatant. The 
BCA protein quantification method is a colorimetric way based on the bicinchoninic acid (BCA). This 
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method is based on the reduction of copper 2+ to copper 1+ by the protein sample in alkaline medium 
(Biuret reaction) and uses the precise colorimetric and sensitive detection of the copper 1+ by 
bicinchoninic acid. The product of this reaction is purple by the reaction of two molecules of BCA with 
one molecule of copper 1+. The water soluble complex can be measured at 562nm, increasing in a 
linear fashion according to the protein amount in the range from 20 to 2000 µg/ml. To quantify the 
protein extract from P. salmonis during infectious process the commercial kit PierceTM BCA Protein 
Assay Kit (Pierce) was used. To quantify the samples it is necessary to prepare a standard curve with 
several dilutions in the range from 25 to 2000µg of albumin from BSA stock. This assay was performed 
in a 96 well plate adding 200µL of BCA reactive plus 25µL of each diluted 1:25 samples (sample: water) 
or each standard curve point. Then the plate was incubated at 37°C for 30 minutes. After the 
incubation time the plate was read at 562nm and the concentration of the sample was measured 
according to the standard curve. All the samples were analyzed twice. 
 
2.2.5 HENS/RATS INOCULATION WITH SYNTHETIC PEPTIDES 
 
Three hens and six rats were immunized with synthetic peptides, each with specific peptide according 
to analysis from the putative DotH, DotG and SdhA proteins from P. salmonis (table 2). The 
conjugation of the synthetic peptide was made as follows: the synthetic peptide was resuspended in 
Sodium Borate buffer pH 9 at 2mg in 225µL. This 225µL (8µg/µL) of resuspended peptide were 
conjugated with 6.7µL of Hemocyanin blue carrier (BioSonda S.A.)(1mg from stock 150mg/mL), 77µL 
of glutaraldehyde 2.5% in sodium borate buffer pH 9. This mixed solution was stirred overnight at 
room temperature in Eppendorf tubes. The next day the solutions were dialyzed against 0.15M NaCl in 
dialysis membranes with an 8 kDa cut off with shaking at 4°C. After this step the conjugated peptide 
(5µg/µL) was recovered in a new Eppendorf tube and stored at 4°C until use. 
For each animal according to its weight a first injection of 200-300µg (rats and hens respectively), and 
100 and 200µg for the subsequent injections were used. The emulsion was prepared as follows: the 
conjugated peptide was used and mixed with Titermax Gold Adjuvant in equal proportion as the 
conjugated amount used (v/v). All the mixes were prepared with PBS 1X to obtain the right volume to 
inoculate at least 5 injection sites in the back (sub-cutaneous) of the rats and in the breast of the hens 
(intramuscular). The pre immune sera and the pre immunized eggs were collected before the first 
inoculation as a control for the antibody production. After 2 months the sera from rat bloods were 
collected by centrifugation at 3500xg at 4°C. The eggs collection was performed using the protocol 
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described by Akita and Nakai (1992), and modified in our laboratory. The eggs were collected after the 
first immunization and the IgY purification was carried out from a “pool” from these eggs. Briefly, the 
yolk was separated from the white part and softly washed with distilled water over a smooth paper. 
Then, the yolk was punctured with a sterile syringe needle and transferred into a test tube; it was diluted 
10 times with sterile water and the pH was changed to 5.2 with 0.1N HCl. This solution was incubated 
at 4°C overnight without shaking to induce the formation of the lipids microspheres. Next day this 
emulsion was filtered with Whatman paper and funnel to separate the lipids from the clear solution. 
The proteins from the filtered solution were precipitated using 35% of ammonium sulfate for 30 
minutes with shaking at 4°C. Then, the suspension was centrifuged for 25 minutes at 10000xg at 4°C. 
The supernatant was recovered in a test tube and it was precipitated again now with 30% of ammonium 
sulfate to reach a final concentration of 65% and incubated for 30 minutes with shaking at 4°C. Then 
the mix was centrifuged at 10000xg for 25 minutes at 4°C. After that, the recovered pellet was 
resuspended in antibody buffer BSA 1X pH 7.6 (NaCl 0.25M 14,61 g/L; NaH2PO4 2.9mM 0,4g/L; 
Na2HPO4 7.1 mM 1,008g/L; BSA 15mM 1500mg/L) for each yolk and the solution was dialyzed 
against 2L antibody buffer without BSA using dialysis membrane with 12kDa cut-off. Finally, both 
polyclonal antibodies were stored separately in aliquots at -20°C until use. 
 
2.2.6 SDS-PAGE ANALYSIS 
 
To perform polyacrylamide gel electrophoresis in denaturant condition, Mini protean III system from 
BioRad was used, following the protocol developed by Leammli (1970) in which the separator gel was 
prepared at a final concentration of 15% of Acrylamide/Bis-Acrylamide 29/1 in Tris-HCl buffer (1,5M; 
SDS 10% pH 8.8) and polymerized using 400µL of ammonium persulfate 10% and 16µL of TEMED 
0.2% as catalyzer. The spacer gel was prepared with Acrylamide/Bis-Acrylamide 29%/1% at a final 
concentration of 4% in Tris-HCl buffer (0,5M; SDS 10% pH 6.8) and polymerized with 80µL of 
ammonium persulfate 10% and 8µL of TEMED as catalyzer. To characterize the protein pattern, 20µg 
from all samples of free cell liquid medium bacteria and from the infectious process induced by this 
bacteria, were separate in the SDS-Gels using a 5X loading buffer (Tris-HCl 62,5mM pH 6.8; SDS 2%; 
glycerol 10%; β-mercaptoethanol 10%; Bromophenol blue 0,01%). All the samples were denatured 
before the electrophoresis by heating at 95°C for five minutes. The running buffer (Tris 250mM, 
glycine 190mM, SDS 0,01%) was used for all the SDS-gels applying an electric field of 70 Volts for 2 
and a half hours approximately. To visualize the protein pattern in the gels the Coomasie blue staining 
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(methanol 40%; acetic acid 10%; Coomasie blue R-250 0,1%) was used for 2 hours and then washed 
with destaining buffer (methanol 30%; acetic acid 7%). Finally, the gels were dried with a Dry Gel 
Buffer (22% ethanol, 2% glycerol, 1% 2-propanol, mixed in distilled water) to get the images with 
Fluorshot, using the equipment SC750, BIOSENS. 
 
2.2.7 WESTERN BLOT ANALYSIS 
  
For western blot analyses the electrophoretic samples described above were used. The proteins were 
blotted to a PVDF membrane, using the Bio-Rad blotting system (Trans-Blot SD), with blotting buffer 
in an electric field with 450 mA for 100 minutes at 4°C. Then, with the proteins in the PVDF 
membrane, the protein free spaces were blocked with blocking buffer (TBS 1X, 0,1% (v/v) Tween-20, 
10% (p/v) powder milk) during one hour with shaking at room temperature. Then, the membranes 
were incubated with dilution of the first polyclonal antibody in different blocking buffer (TBS 1X, 0.1% 
(v/v) Tween-20, 3% (p/v) powder milk) overnight at 4°C. Thereafter, the membranes were washed 
with washing buffer (TBS 1X, 0.1% (v/v) Tween-20) three times ten minutes each with shaking, at 
room temperature. Then, the membranes were incubated with a dilution (1:2000) of the secondary 
antibody conjugated with horse-radish peroxidase (HRP) against the animal model used (rat or hen) in 
the same blocking buffer for the first antibody during at least two hours at room temperature with 
shaking. Thereafter, the membranes were washed again with washing buffer three times ten minutes 
each with shaking at room temperature. Finally, the interaction between antigen and antibody was 
detected with commercial kit ECL Pierce Western Blotting Substrate, based on a chemiluminescent 
reaction where the substrate is coupled with the HRP. The images were obtained with the G-BOX 
Chemi XT4, SYNGENE. 
The polyclonal antibodies used in these western blot analyses were from the animal models (rat and 
hen) induced by synthetic peptides. The dilution for the primary antibody was standardized at 1:250 for 
each polyclonal antibody, and for the secondary antibody, the standard dilution was 1:2000. The sample 
amount used in SDS-PAGE was 20µg of total protein extract from infectious process induced by P. 
salmonis in cell line SHK-1. 
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2.2.8 ANTISENSE OLIGONUCLEOTIDES TECHNIQUE 
 
Using the nucleotide sequence from the partial genome of the strain AUSTRAL-005 from P. salmonis, 
the Shine-Dalgarno sequence in the possible dotH, dotG and sdhA genes (table 2) was used to design the 
Antisense Oligonucleotides (ASO). The ASO were applied to cells by electroporation to inhibit 
translation of the respective genes. For electroporation assay, a 10% glycerol solution containing each 
ASO in a final concentration of 500nM was used. For these experiments, the bacteria were grown in 
AUSTRAL-SRS broth for 5 days (exponential growing phase). Then 1mL of bacteria was collected in 
separate 1.5mL Eppendorf tubes by centrifugation at 3500xg for ten minutes at 4°C. After that, the 
medium was replaced by a mix between 10% glycerol and 500nM of each ASO (100µL final volume 
mix). The electroporation experiment was carried out in Eppendorf Multiporator using 1000Volts and 
sterile cuvettes with caps. Once the bacteria were electroporated, this 100 µL mix was inoculated in 
AUSTRAL-SRS broth medium until the fifth day of growth to extract total proteins and carry out the 
western blot analyses with specific antibodies against DotH, DotG and SdhA proteins. 
 
2.2.9 MULTIDIMENSIONAL PROTEIN IDENTIFICATION BY MASS 
SPECTROMETRY (MudPIT) 
 
2.2.9.1 PROTEOLYSIS 
 
The lyophilized proteins were resuspended in 6M guanidine hydrochloride, 25mM NH4HCO3, 
pH 7.5, and reduced with 2mM dithiotreitol (DTT) for 30 min at room temperature, and then 
alkylated by 10mM iodoacetamide for 30 min in darkness at room temperature. The reaction 
was diluted 7 times with 25mM NH4HCO3, pH 7.5 and 2µL of 0.1ng/mL of modified trypsin 
(Promega) was added. The trypsin reaction was incubated 16h at 37°C. The reaction was 
terminated by addition of acetic acid to pH 2.0.  
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2.2.9.2 MULTIDIMENSIONAL PROTEIN IDENTIFICATION BY MASS 
SPECTROMETRY (MudPIT) 
 
All samples were concentrated on a centrivac concentrator (Labconco) to a final volume of 
20µL and loaded on a 350µm ID fused silica 2D HPLC triphasic peptide trap column packed 
in-house with 3cm of a desalting C18 reversed phase (100Å, 5µm, Magic C18 particles, 
Michrom Bioresources), followed by 3cm of a strong cation exchange column (300Å, 5µm 
PolySULFOETHYL A, PolyLC inc) and finally with 3cm of resolving C18 reversed phase. 
The peptide trap was mounted on the loop of a nanlLC (ThermoFinnigan). Following a wash 
with 0.1% formic acid for 30 min at 0.5µL/min, the efflux of the peptide trap column was 
directed to a 10cm resolving reversed phase column (100Å, 5µm, Magic C18 particles, 
Michrom Bioresources), mounted on the electrospray stage of a FT IC mass spectrometer 
(LTQ FT, ThermoFinnigan). The peptides were separated on-line using 15 salt steps (0, 10, 30, 
50, 100, 150, 200, 250, 300, 350, 400, 500, 1000, 1500, and 2000mM NH4CH3OO) followed by 
a 0 – 90% acetonitrile gradient in 120min at flow rate of 350nl/min. An electrospray voltage of 
1.9kV was used, with the ion transfer temperature set to 250°C. The mass spectrometer was 
controlled by the Xcalibur software to perform continuously mass scan analysis on the FT 
followed by MSMS scans on the ion trap of the six most intense ions, with a dynamic 
exclusion of one repeat scans of the same ion, 30s repeat duration and 90s exclusion duration. 
Normalized collision energy for MS/MS was set to 35%. 
 
2.2.9.3 DATA ANALYSIS 
 
For data analysis all tandem mass spectra all MS/MS samples were analyzed using Sequest 
(Eng et al., 1994), included in the proteome discoverer package (Thermo Fisher Scientific, San 
Jose, CA, USA; version 1.4.0.288) and X! Tandem (The GPM, thegpm.org; version 
CYCLONE (2010.12.01.1)). Sequest was set up to search uniprot-
Piscirickettsia+salmonis.fasta (9279 entries) assuming the digestion enzyme trypsin, and a 
maximum of 2 missed cleavages. X! Tandem was set up to search the same protein database 
28 
 
(also assuming trypsin). Sequest and X! Tandem were searched with a fragment ion mass 
tolerance of 0.80Da and a parent ion tolerance of 50PPM. Carbamidomethyl of cysteine was 
specified in Sequest and X! Tandem as a fixed modification. Deamidation of asparagine and 
glutamine and oxidation of methionine were specified in Sequest as variable modifications. 
Dehydrated of the n-terminus, glu->pyro-Glu of the n-terminus, ammonia-loss of the n-
terminus, gln->pyro-Glu of the n-terminus, deamidation of asparagine and glutamine and 
oxidation of methionine were specified in X! Tandem as variable modifications.  
 
2.2.9.4 CRITERIA FOR PROTEIN IDENTIFICATION 
 
Scaffold (version Scaffold_4.4.1.1, Proteome Software Inc., Portland, OR) was used to validate 
MS/MS based peptide and protein identifications. Peptide identifications were accepted if they 
could be established at greater than 72.0% probability to achieve an FDR less than 0.5%. 
Peptide Probabilities from X! Tandem were assigned by the Peptide Prophet algorithm (Keller 
et al., 2002) with Scaffold delta-mass correction. Peptide Probabilities from Sequest were 
assigned by the Scaffold Local FDR algorithm. Protein identifications were accepted if they 
could be established at greater than 99.0% probability and contained at least 1 identified 
peptide.  Protein probabilities were assigned by the Protein Prophet algorithm (Nesvizhskii et 
al., 2003). Proteins that contained similar peptides and could not be differentiated based on 
MS/MS analysis alone were grouped to satisfy the principles of parsimony. Proteins were 
annotated with GO terms from NCBI (downloaded Mar 26, 2015) (Ashburner et al., 2000). 
 
2.2.10 STATISTICAL ANALYSIS 
 
All the experiments were done in triplicate showing the average data plus standard deviation (Analysis 
of Variance, ANOVA, Sokal y Rohlf, 1980). The significances between the results and controls were 
established using t Student’s test and it was used the P value significance of P<0.05. 
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3. RESULTS 
 
Piscirickettsiosis is caused by Piscirickettsia salmonis, a Gram-negative facultative intracellular 
pathogen, that infects salmonids fish species inducing highly mortality and economic losses in 
salmon farming industry in Chile. This pathogen has the ability to replicate inside the infected 
cell (Gómez et al., 2013). Currently, there is only limited knowledge about how this bacterium 
can establish the infection in macrophages, using the GSP Sec-dependent pathway and type 4B 
secretion system (T4BSS) to translocate effector proteins that subvert the infected cell to its 
own benefits (Gómez et al., 2013). To evaluate this task, specific genes belonging to Sec-
dependent pathway and T4BSS were looked for in the partial genome of AUSTRAL-005 strain 
available in our laboratory. 
 
3.1 BIOINFORMATIC ANALYSIS 
 
As a first step, genes belonging to the GSP Sec-dependent pathway and T4BSS were looked 
for in NCBI database, described for several pathogens, focused in Legionella penumophilla and 
Coxiella burnetii. After that, conserved domains present in each multiple alignment were looked 
for in the partial genome of Piscirickettsia salmonis AUSTRAL-005 strain. The possible genes 
found were secY, secE, secG, secD, secF, yajC and yidC for Sec-dependent pathway, several icm/dot 
genes for T4BSS and sdhA gene described as an effector protein to T4SS (figure 6). Genes 
from Sec-dependent pathway were found in different contigs, however, the proteins that form 
the secondary holotranslocon SecDF/YajC were found in the same contig in the same strand. 
The gene for the auxiliary protein YidC from Sec-dependent pathway was found in a different 
contig; genes from T4BSS were all found grouped in the same contig separately each other in 
three copies in the bacterial genome. The T4SS described effector protein SdhA was found 
alone in a different contig. 
Once, all the possible genes for the Sec-dependent pathway, T4BSS and effector protein were 
found in the genome, a multiple alignment was made to compare the derived aminoacid 
sequences of sdhA genes from L. pneumophila and P. salmonis among other sequences present in  
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Figure 6: Bioinformatic analyzes of partial genome from Piscirickettsia salmonis AUSTRAL-005 
strain to predict the putative location and genes of GSP (Sec-dependent) Contigs 227 and 172, 
T4BSS (Dot/Icm) Contigs 136, 216 and 21, and the putative effector protein SdhA Contig 
167. 
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NCBI database (figure 7). The comparison revealed the similarities among all these proteins 
described in the databases even the possible SdhA protein from P. salmonis.  
 
3.2 SPECIFIC GENE DETECTION 
 
Using the information obtained above, specific primers were designed to amplify the secD, secF, 
yajC, yidC, dotG, dotF, dotH and sdhA genes from RNA extracted during an in vitro infection on 
SHK-1 cell line after short times (0h, 2h, 8h, 16h, 24h) and long times (2d, 4d, 6d) induced by 
the bacteria (figure 8). For standardization of the primers gradient conventional PCR was 
performed using 57°C, 60°C, and 62°C to check specific amplification of the PCR products. 
According to the results, 60°C for all the qRT-PCR experiments was chosen as annealing 
temperature (table 1). 
A minimal amount of two primers for each candidate gene were used and checked for PCR 
amplification choosing the better primer pair from each gene. As a normalizer gene 23S rRNA 
specifically designed from P. salmonis AUSTRAL-005 strain was used. To check also the 
specificity of the primers, DNA and RNA from other bacteria like E. coli and Francisella 
noatunensis was used, where amplification wasn’t observed at the same conditions used to the 
previous qRT-PCR. 
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Figure 7: multiple alignment of SdhA aminoacid sequence from P. salmonis (01), L. pneumophila 
(02), C. burnetii (03) and E. coli (04). 
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Figure 8: primer standardization using different annealing temperatures (T1: 57°C; T2: 60°C; 
T3: 62°C) to amplify the transcript from secD, secF, yidC, yajC, dotG, dotH, sdhA and 23S genes 
in Piscirickettsia salmonis. The 23S primer was used to normalize and was specifically designed to 
detect P. salmonis strain AUSTRAL-005. 
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Table 1: primers used to detect the transcript of Sec-dependent pathway, T4BSS and sdhA 
genes. 
 
Primer name Sequence Putative Gene 
DotH 
Fwd-TTACCAATGCTCCGGCAACT 
dotH/icmK 
Rev- GCCGGTGAGATTAACGTTCC 
DotG 
Fwd- AACAAGTGCAGCAACCGAGA 
dotG/icmE 
Rev- GACCGTTGGTGGCCGATTA 
DotF 
Fwd- CAATTATTACTGGGCGGGCTTG 
dotF/icmG 
Rev- AACCCAGAGCTCGTGATAACTTT 
SdhA 
Fwd- ATCGCGGTGGTAACGAAAGT 
sdhA 
Rev- CATGTGCCAACGCCAATCAT 
SecD 
Fwd- CGAGACTCCTGGTGGAAGGT 
secD 
Rev- TCACATCAAAGCCACGACGA 
SecF 
Fwd- CCAAAGCGCAGGCTTAAGTG 
secF 
Rev- AACCGGTTGGCCTAATGTCA  
YajC 
Fwd- TCCACAAAGTAAGCGTGCCA 
yajC 
Rev- CACTTTACCCAACACACCGC 
YidC 
Fwd- GGCAATTGCAGTATGGGCCT 
yidC 
Rev- TCAGCAGATCGCGTGTTAGT 
23S 
Fwd- TTGAAAACCGGTGTTGAGAT 
23S 
Rev- CTCTAACTGCCAAGGCATCC 
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3.3 RELATIVE QUANTIFICATION 
 
Once the primers were standardized, they were used to evaluate the expression levels of the 
Sec-dependent pathway and the T4BSS genes during infectious process induced by P. salmonis 
in cell line SHK-1. 
The putative genes from Sec-dependent pathway and T4BSS were amplified successfully using 
specific primers and the relative level of expression during an infectious process is shown in 
figure 9. It is very probable that both secretion systems can act together to translocate 
substrate into the cytosol of the host cell but it is needed to verify if the gene product is 
present during the infectious process induced in the same conditions used earlier. 
Different patterns of gene expression were observed for each gene during in vitro infection. 
Genes belonging to the T4BSS increased at early times post infection, from 2hpi until 2dpi, 
showing a decreased expression after 4dpi. Genes belonging to Sec-dependent pathway 
showed increased levels from 8hpi showing a peak of increased expression at 24hpi continuing 
with high levels of transcripts until the end of the experiment at 6dpi. The expression of the 
auxiliary protein YidC showed a similar pattern like SecDF/YajC holotranslocon increasing 
from 8hpi until the end of the experiment.  
The expression pattern for sdhA gene showed early increase from 8hpi with a peak at 4dpi to 
decrease after this since 6dpi but continuous higher than the calibrator point until the end of 
the experiment. 
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Figure 9: relative quantification of expression levels from secD, secF, yajC, yidC (upper panel) 
and dotH, dotG and sdhA (lower panel) genes during infectious process induced by P. salmonis in 
SHK-1 cell line normalized with 23S gene. 
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3.4 ANTIBODY PRODUCTION 
 
After the successful detection of specific transcripts from T4BSS, Sec-dependent pathway and 
effector protein genes, it was decided to generate polyclonal antibodies using the aminoacid 
sequence derived from nucleotide sequence from the same possible candidate genes 
dotH/icmK, dotG/icmE and sdhA from P. salmonis AUSTRAL-005 strain genome, to analyze 
them and look for the best antigen to design synthetic peptides. 
In the beginnings of this research the sequence for these three proteins in this pathogen was 
not available. So the design was made by choosing the possible proteins of the Type 4B 
Secretion System described in Legionella pneumophila and Coxiella burnetii, comparing with 
Piscirickettsia salmonis AUSTRAL-005 strain genome. Currently, are available the annotated 
proteins described for this Secretion System in the complete genome of Lf-89 strain by Pulgar 
et al. (2015). 
The aminoacid sequence analysis was made by online server using the Kolaskar and 
Tongaonkar (1990) method to predict antigenic determinants along with other parameters like 
hydrophilicity, surface accessibility and linear epitope prediction (fig. 10) to predict the best 
antigens to design synthetic peptides (table 2). 
Once the synthetic peptides were synthetized they were analyzed against online protein 
database. The three synthetic peptides show between 75 to 100% of aminoacid sequence 
identity with the annotated proteins DotH, DotG and SdhA in P. salmonis (fig. 11) LF-89 
strain. 
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Figure 10: aminoacid sequence analysis of DotG, DotH and SdhA proteins to look for the 
best antigens of each protein for synthetic peptide design. The red boxes show approximately 
the position of the synthetic peptides that were made. 
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Table 2: synthetic peptides designed to generate polyclonal antibody in animal model. 
 
PROTEIN 
NAME 
SYNTHETIC PEPTIDE ACC. NUMBER 
DotH LSGVLMVQGIKPYGQT A0A0B8UZN4 
DotG NHQNLQEEKEQQEVDQYQLKVS A0A0B8V3N1 
SdhA KHTLYFSDDHKIS A0A0B8UP92 
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Figure 11: aminoacid sequence of DotH, SdhA and DotG from database showing the 
synthetic peptide (highlighted in red) synthetized to generate polyclonal antibodies. 
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The main purpose was to generate polyclonal antibodies against DotG, DotH and SdhA 
proteins from P. salmonis AUSTRAL-005 strain.  
After three months of inoculation with synthetic peptides in two different animal models (hens 
and rats) the polyclonal antibodies from hen yolk and rat sera for all three proteins DotH, 
DotG and SdhA from P. salmonis were obtained.  
Then their characterization was started through dot blot and western blot assays comparing 
them with the sera and yolk previous to the immunization with the synthetic peptides as a 
control antibodies (pre-immune sera). These antibodies were used against the AUSTRAL-005 
and LF-89 strains growing in liquid medium to detect the described DotH, DotG and SdhA 
proteins in L. pneumophila and C. burnetii. 
The results show the best dilution (1:250 primary antibody) for each polyclonal antibody 
detecting several protein bands in those samples from liquid medium (figure 12). 
For the two strains used of P. salmonis, positive reaction for DotH and DotG was detected at 
the relative theoretical mass derived from the aminoacid sequence, 21kDa and 45kDa 
respectively; the only antibody that reacted in a different relative theoretical mass with 
approximately 50kDa was SdhA protein (65kDa theoretical). 
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Figure 12: immunedetection of SdhA, DotG and DotH (red arrows in each panel) proteins 
with polyclonal antibodies. The bacterium was cultured in AUSTRAL-SRS broth and the 
samples were extracted at fifth day post inoculation in fresh medium. The dilution for each 
polyclonal primary antibody was 1:250 and the specific positive signal was detected in both 
strains at the same amount of total protein in each lane (40µg). 
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3.5 PROTEIN DETECTION BY POLYCLONAL ANTIBODIES 
 
Using total protein extracts from P. salmonis AUSTRAL-005 strain, a proteome analysis was 
made to visualize the whole range of proteins that exists in the bacteria growing in liquid 
medium at exponential phase. From this result it was found that around 15% of these proteins 
are involved in other process than metabolism and those without determined function. And 
inside this type of other processes the transport processes are found which are involved the 
Type 4B Secretion System among others (fig. 13). 
To prove this statement it was looked for the presence of the Dot/Icm proteins, Sec-
dependent pathway and the effector protein SdhA in the bacterial proteome. It was really great 
to find almost all the proteins described to T4BSS from L. pneumophila and C. burnetii in the 
proteome of P. salmonis. Likewise the proteins described to Sec-dependent pathway and the 
effector protein SdhA (table 3).  
The core proteins of the T4BSS are present in the proteome, namely DotH, DotG, DotF, 
DotC and DotD, as well as, the effector protein described in L. pneumophila, SdhA. Also other 
important proteins in the same secretion system are present like chaperones and ATPases. For 
the Sec-dependent pathway the core complex that forms the SecDF-YajC holotranslocon 
together with SecB and SecA was found (table 3). 
Using the standardized antibodies already made, denaturant electrophoresis in polyacrylamide 
gels (SDS-PAGE) was performed in order to separate the total protein extract samples to 
analyze for the presence of DotH, DotG and SdhA during in vitro infection induced by P. 
salmonis in SHK-1 cell line (figure 14). Silver staining was used to verify the protein pattern in 
each lane. The total protein amount in each lane was 20µg. 
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Figure 13: Proteome analysis of Piscirickettsia salmonis AUSTRAL-005 strain. Here is shown the 
proteome analysis of the AUSTRAL-005 strain where are highlighted the proteins involved in 
the transport mechanism which probably should be present the Type 4B protein Secretion 
System among others. 
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Table 3. Proteome analysis of P. salmonis showing the proteins belonging to the Type 4B 
Secretion System, Sec-dependent pathway and effector protein (Dot/Icm, Sec proteins and 
SdhA respectively). Score, times detected, coverage, percentage of protein found, #peptides, 
number of peptides from the detected protein. The proteins DotH, DotG and SdhA are 
highlighted. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Acc. Number Description Score Coverage # Peptides 
A0A095BUI2 DotD 11,03 97,02 10 
A0A095CP73 DotB 2,56 76,6 17 
A0A095BKQ6 IcmW 2,33 66,43 7 
A0A095BT71 IcmK/DotH 11,75 65.59 12 
A0A095DSE8 IcmO 7,53 48,44 33 
A0A095BIW8 DotA 14,79 40,52 24 
A0A0B8V6U7 IcmG/DotF 5,73 64,12 26 
A0A0B8V979 IcmE/DotG 4,23 42,07 25 
A0A0B8UR39 IcmB 4,99 41,87 55 
A0A0B8UG95 SdhA 30,56 50,43 44 
A0A0B8UK28 SecA 20,00 44,18 64 
A0A0B8UNG4 SecD 9,69 34,89 29 
A0A0B8V1U5 SecF 3,87 27,07 17 
A0A0B8UVN9 SecB 2,02 20,12 3 
A0A0B8V9Y9 YajC 6,65 24,79 4 
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Figure 14: Western blot analyzes detecting DotH, DotG and SdhA from P. salmonis during an 
infectious process in SHK-1 cell line (20 µg total protein each lane). 
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3.6 ANTISENSE OLIGONUCLEOTIDE ASSAY 
 
After the detection of transcripts and proteins DotH, DotG and SdhA, it was aimed to 
determine the possible function of SdhA protein during in vitro infection induced by P. salmonis. 
First at all, the aminoacid sequence of SdhA protein from P. salmonis (described in L. 
pneumophila) was analyzed by online programs that predict effector proteins using several 
parameters described for Yejun et al. (2014). The algorithm used was able to predict around 
81% of Legionella effectors among them the Type 4 effector proteins. With this training data, 
the aminoacid sequence of SdhA from P. salmonis was analyzed comparing it with other 
proteins related to T4BSS. Among these proteins, PmrA is a gene regulator protein for T4BSS 
described in Legionella and Coxiella (Zusman et al., 2007), and in this case it was used as a 
negative control for effector protein. The results show that SdhA from P. salmonis was 
identified as an effector protein as well as the positive control VipE (effector protein described 
in Legionella), compared to PmrA protein from P. salmonis, that was found negative as an 
effector protein as expected (table 4). 
Before this analysis was done, it was found that this pathogen, like other Gram-negative 
bacteria, produces Outer Membrane Vesicle (OMV). Here it is demonstrated by Oliver et al. 
(2015), that this pathogen produces OMVs when is growing in liquid medium and during an in 
vitro infection (fig. 15). In figure 15 in panels B, C, E and F is visualized the OMV production. 
In B and E TEM images from the formation and release of this vesicles and in C and F SEM 
images that show the form and the approximated size of the OMVs produced by P. salmonis. In 
the same image 15, is visualized the OMVs during in vitro infection (black arrow head) near to 
the bacteria (Ps). The size of these OMVs is variable with a mean size of 45 nm. 
Inside of these OMVs there are a lot of proteins, RNA and DNA, all of which “try” to modify 
the environment to its own benefits, like a first step of infection establishment. In this context, 
effector proteins like SdhA should be present inside this vesicle. To support that statement, the 
proteome of a sample of these OMVs was determined and the presence of a few peptides 
belonging to the SdhA protein from P. salmonis was found, proving that this protein should be 
an important factor during infection. 
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Table 4. SdhA from P. salmonis as an effector protein predicted by T4SEpre and T4EffPred. 
None of  the chaperons (HtpB and Hsp60) were identified as a Type 4 effector protein 
(negative controls). T4SEpre utilize algorithm SVM (Support Vector Machines) based on 
training data to classify the new data. A large amount of  effector proteins from T4SS used to 
training the program. This algorithm was able to identify 81% of  Legionella effectors (Yejun et 
al., 2014). The red box shows the positive result for SdhA from P. salmonis as an effector 
protein from T4SS. The PmrA gene regulator protein from P. salmonis was negative as an 
effector protein, as expected. 
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Figure 15: Production of Outer Membrane Vesicles (OMVs) from P. salmonis. Transmission 
Electron Microscope images (A and D) of OMVs from P. salmonis (Ps) infecting SHK-1 cells 
(head arrows), and also is shown the formation (B) and released (E) of OMVs from bacterium. 
Scanning Electron Microscope (SEM) images shown the shape and approximately the size of 
the OMVs produced by P. salmonis (Oliver et al., 2015). 
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The OMV proteome was determined to look for the presence of the SdhA inside this vesicle. 
The results show that twelve peptides aligned with the aminoacid sequence of SdhA from P. 
salmonis (Table 5).  
Doing further analysis with P. salmonis AUS-005 genome, a gene regulator protein PmrA was 
found that regulates the gene expression of T4BSS and some T4SS effector proteins described 
for Legionella and Coxiella by Zusman et al. (2007). Using the nucleotide sequence of PmrA, a 
phylogenetic analysis was done to compare it with other bacteria as well as with sdhA gene. 
The nucleotide sequence of pmrA gene from P. salmonis was located near to Legionella pmrA 
gene sequence (fig. 16).  
Then, a multiple alignment between PmrA proteins from P. salmonis LF-89, C. burnetii, E. coli, 
L. feeleii and P. salmonis AUS-005 (fig. 17) was calculated. In all the sequences the motif 
described by Zusman et al. (2007), for PmrA, LEVHIHNLR was found (red line below the 
sequence in fig. 17). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
51 
 
 
Table 5. SdhA peptides sequence from P. salmonis OMVs proteome identified from trypsin-
digested gel by LC-MS/MS.  
 
 
     
 
 
  
 
 
 
 
52 
 
 
 
Fig. 16: Phylogenetic analysis of pmrA gene from P. salmonis. Nucleotide sequence analysis of 
pmrA genes described in Gammaproteobacteria belonging to different orders. 
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Fig. 17: Multiple alignment using aminoacid sequence of PmrA proteins described for several 
bacteria compared with Piscirickettsia salmonis Austral-005 strain. The described conserved motif 
for PmrA protein (LEVHIHNLR) is underlined (Zusman, et. al., 2007). 
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Now, after all this previous analysis, and using the nucleotide sequence of the T4BSS genes 
and the effector protein SdhA, it was used to designed Antisense Oligonucleotides (ASO) to 
inhibit the translation of the specific messenger RNA coding for sdhA, dotH, dotG and pmrA 
genes to decrease the protein amount in Piscirickettsia salmonis. An example of the ASO design is 
shown in figure 18.  
Table 6 summaries the ASOs that were used for this experiment. The ASO was designed to 
block the ribosome binding site in each mRNA for the specific gene; electroporation was used 
to deliver it inside the bacteria. With this type of ASO design, western blot analysis were 
carried out to evaluate the protein amount shift using polyclonal antibodies to detect the 
presence of DotH, DotG and SdhA (fig 19). The absence of each protein when the specific 
ASO was used to inhibit the specific mRNA is not completely clear. The presence of each 
protein in each control, and also in the same samples using silver staining (data not shown), 
however indicates that presumably the ASO worked at least in some cases to inhibit the 
translation of the specific mRNA. 
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Fig. 18: antisense oligonucleotides (ASO) design example. Using the nucleotide sequence to 
dotH, dotG and effector protein (sdhA gene), the antisense oligonucleotides were aim to the 
ATG site and the 5’ end sequence to block the ribosomal binding site and therefore block the 
translation of the mRNA. 
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Table 6: Antisense Oligonucleotides (ASO) to inhibit the translation of the specific messenger 
RNA. 
 
GENE 
ANTISENSE 
OLIGONUCLEOTIDES 
ACC. NUMBER 
dotH 
ATGATTACATCGATTGTAAT 
CP011849.1 
dotG 
GTATTTGCTGTACTTGATAC 
CP011849.1 
sdhA 
GGTGTATAATTCATGACAAT 
CP011849.1 
Control 
GCTAAGCATTACACCATTTG 
AC239108.3 
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Figure 19: Western blot analyses to prove the translation inhibition of the SdhA, DotG and 
DotH proteins induced by the ASO treatment. Samples: P. salmonis/ASO-SdhA; P. 
salmonis/ASO-DotG; P. salmonis/ASO-DotH; P. salmonis/ASO-PmrA; P. salmonis/ASO-Control 
Antisense; P. salmonis/Control without electroporation. Total amount of protein extract in each 
lane was 80 µg. Silver staining of the same samples was used as a loading control (data not 
shown).  
 
 
 
 
58 
 
4. DISCUSSION 
 
Using the available genome of P. salmonis AUSTRAL-005 strain, sequenced in our laboratory, it 
was analyzed for the putative genes belonging to bacterial protein secretion systems. At the 
moment of writing, genes for almost all the secretion systems were found, but just the Type 4B 
Secretion System (T4BSS) was nearly complete compared with the T4BSS described for L. 
pneumophila. The proteins belonging to the core of the T4BSS were complete so those proteins 
were further analyzed. With the currently latest assembled nucleotide sequence, the T4BSS 
genes were identified in three contigs. Only one contig (136) evidenced all the Dot/Icm genes 
described for L. pneumophila and C. burnetii, supporting strongly the idea that this secretion 
system could be acting during the infection process (fig 6). In agreement with the latest article 
published by Pulgar et al. 2015, they also described three copies of the same T4BSS genes in 
the genome of P. salmonis LF-89. The redundancy of the gene copy amount of this secretion 
system is a disadvantage energetically speaking; but otherwise it is advantageous when the 
bacteria are infecting cells, so the RNA polymerase can easily find the genes and transcribe 
them (Klappenbach et al., 2000). The presence of multicopy genes in bacterial genomes 
contributes to a better adaptation to environmental stress (Kondrashov et al., 2002). 
Also found were genes belonging to General Secretion Pathway (GSP or type 2 secretion 
system), specifically the Sec-dependent pathway (fig. 6) described in E. coli (Xie and Dalbey, 
2008). This Sec-dependent pathway also plays a prominent role in protein export and secretion 
in bacteria. It is also worth to note that all the components forming the secretion apparatus 
from type 1 to 6 secretion system are membrane inserted or exported by the Sec system 
(Dalbey and Kuhn, 2012). 
It is of importance to have found and to analyze the Sec-dependent pathway and the T4BSS in 
this fish pathogen to help us to understand the behavior of this bacterium and how we can 
design new strategies to avoid the disease in salmon farming. 
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Continuing with the search of possible key factors in bacterial genome, a possible effector 
protein in P. salmonis AUSTRAL-005 strain was found. Using conserved motifs between 
effector proteins described in L. pneumophila and C. burnetii, and among other bacteria in the 
NCBI database, the sdhA gene (fig. 6) was found, described as a key protein in L. pneumophila, 
involved in the integrity maintenance of vacuolar membrane inside the host cell (Creasey and 
Isberg, 2011). The aminoacid sequence of SdhA derived from the nucleotide sequence found 
in P. salmonis was used for a multiple alignment with the respective SdhA aminoacid sequences 
described for L. pneumophila, C. burnetii and E. coli. The similarity between these sequences is 
very high around 70% at least and makes one suppose that perhaps this protein has the same 
function in P. salmonis (fig. 7). One of the mechanisms proposed to SdhA in Legionella, beside 
to maintain the integrity of the membrane vacuole, is to inhibit the apoptosis to allow the 
bacteria to grow inside the host. In fact, Wall and McCormick (2014), sum up that bacterial 
infection has the ability to manipulate the activation or inhibition of programmed cell death. 
There are two possible ways to inhibit the apoptotic pathway. One of them is the inhibition of 
Caspase-3 using some yet unidentified T4SS substrate or mediating the activation of pathways 
that prevent the Caspase-3 activity. In both processes, the bacteria prolong the time to 
replicate inside the host cell to ensure its survival. Studies using the human pathogen Legionella 
pneumophila with a mutated SdhA protein showed that this bacterium cannot establish the 
infection inside the cell (Creasey and Isberg, 2011). So, if this protein is present in P. salmonis 
during in vitro infection, SdhA could act in the same manner like it does in Legionella.  
Inhibition of the SdhA translation perhaps could stop or delay the progression of in vitro 
infection. Maybe, if the translation could be blocked successfully by using ASO and then infect 
the cells with this treated bacteria, the viability of this microorganism would be less than 
pathogenic bacteria without ASO treatment, because when the Legionella SdhA protein is 
truncated or depleted this bacterium cannot grow inside the cell (Isberg et al., 2009). 
At this moment, the detection of the proteins during the progression of in vitro infection give 
us a clue to begin to understand how the bacteria establish the infection and the key factors 
that this pathogen used to subvert all the enzyme mechanism to its own benefit.  
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According to the qRT-PCR results, the expression levels of sdhA gene during in vitro infection 
suggest that this protein could be acting during this process.  
Further results from our laboratory looked for the expression levels of sdhA together with the 
expression levels of caspase-3 genes, during an in vitro infection; the pathogenic bacteria showed 
increased sdhA gene expression levels compared with decreased caspase-3 gene expression 
levels. On the other hand, when the bacteria were inactivated the sdhA gene expression levels 
are decreased and caspase-3 are increased (unpublished data). 
The gene for effector protein SdhA was also found overexpressed (fig. 9) during in vitro 
infection starting very early (2h post infection) with a peak at around 8h post infection; this 
expression levels was constant during the whole experiment. This could be related to the 
function that T4BSS gene clusters are doing during the infection because at early times bacteria 
need to inject effector proteins to subvert the host cell mechanism to its need and establish the 
infection in order to survive and replicate inside the vacuole. Although the gene expression 
levels for the T4BSS are not so striking, they are correlated with the gene expression levels of 
SdhA, and this effector protein is described as a T4SS substrate in L. pneumophila (Laguna et al., 
2006). 
The gene expression levels for the Sec-dependent pathway perhaps are correlated also with the 
protein export of another substrate from T4SS that remains unidentified (fig. 9). One other 
explanation could be the increased amount of replicating bacteria inside the vacuole and their 
need to assemble the inner, outer and periplasmic space proteins. The Sec-dependent pathways 
are described to help in this function and also other types of secretion systems (Dalbey and 
Kuhn, 2012). The expression levels of the Sec-dependent pathway genes were different; 
perhaps because of the amount of proteins needed to assemble the holo-translocon 
SecDF/YajC (Schulze et al., 2013). Also, for the nature of auxiliary protein YidC, the increased 
gene expression levels were observed during in vitro infection maybe are correlated to the 
function that this protein does during the replication of bacteria, translocating proteins from 
cytoplasm to inner membrane and/or periplasmic space by its own (Serek et al., 2004). 
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Combining all the results until now, it can only be said that T4BSS and Sec-dependent pathway 
are functional, but until the presence of these proteins from those genes can be proven, this is 
only a speculation. 
Pursuing this goal synthetic peptides were designed to generate polyclonal antibodies against 
DotH, DotG and SdhA proteins from P. salmonis AUSTRAL-005 strain. 
When the antibodies were generated the pre-sera were taken as pre-immune sera as a control 
for each antibody and then each pre-immune/immune sera were tested individually. The best 
combination of pre-immune and immune sera was chosen to further experiments in western 
blot analysis. 
The results showed that the detection of the proteins was successful. First of all, the proteins 
were immunodetected in liquid medium growing bacteria (fig. 12), and positive reactions for 
the three antibodies in P. salmonis LF-89 and AUSTRAL-005 strains were seen. The predicted 
relative mass for DotH protein (21 kDa) was detected between 20 – 25 kDa using this 
polyclonal antibody. The same positive reaction was seen with this polyclonal antibody against 
DotG protein (43 kDa), detecting a few bands between 40 – 45 kDa. And, for the polyclonal 
antibody against SdhA protein, showed positive reaction between 45 – 55 kDa, lower than the 
expected 65 kDa from the aminoacid sequence. 
Once the proteins were detected in liquid medium growing bacteria, this result was compared 
with the proteome obtained from LF-89 strain. All the proteins belonging to T4BSS, Sec-
dependent pathway and SdhA were found in the proteome (table 3). Moreover, the proteins 
for which polyclonal antibodies were made also were found in the proteome of LF-89 strain, 
corroborating the positive reaction in western blot analysis.  
Another analysis using the aminoacid sequence of SdhA revealed that this protein could be 
substrate for an enzyme and the protein size detected in western blot comes from the 
proteolytic cutting. From the proposed action mechanism to SdhA from Legionella it is possible 
that this protein could be an inhibitor for apoptosis via Caspase (mentioned above), and its 
action blocks the functional site competing with the intracellular substrate to this enzyme, and 
inhibits the cell death (Laguna et al., 2006; Creasey and Isberg, 2011; Wall and McCormick, 
2014). 
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The immunodetection of DotH, DotG and SdhA during in vitro infection was also successful. 
The positive reaction can be closely related to gene expression levels because at early times 
post infection an increase in the level of the three proteins was seen as early as 2h post 
infection with a peak of positive signal between 8h and 16h, decreasing since 2d post infection 
but being still present in the whole infectious process (fig. 14). Although it will be better to 
have a loading control antibody specifically to this pathogen, the silver staining for all the 
samples showed an identical protein pattern during the whole experiment. With this result, it 
can be said that this T4BSS exists in P. salmonis and probably is involved to secrete effector 
proteins inside the host cell including SdhA protein during in vitro infection. 
While the genes mentioned above were searched, also a gene regulator protein for the T4BSS 
named PmrA was found. This protein was described in Legionella to control the expression of 
almost all genes from T4BSS and some T4SS substrate (Zusman et al., 2007). They mentioned 
that this gene regulator protein possess a conserved motif near to the carboxyl terminal (fig. 
17). Looking at the result of this multiple alignment it can be seen that both P. salmonis 
AUSTRAL-005 and LF-89 strains have the same conserved motif described by Zusman and 
co-workers. Using the nucleotide sequence for this protein found in P. salmonis AUSTRAL-005 
strain, a phylogenetic analysis comparing this pmrA gene with other bacteria was carried out 
(fig. 16). The nucleotide sequence was located near to Legionella and gives us a clue to its 
possible function for PmrA from P. salmonis like it does in this human pathogen.  
Then, in an attempt to manipulate the bacteria, the Antisense Oligonucleotide (ASO) 
technique was used combined with electroporation to deliver the ASO inside the bacteria (fig. 
18 and table 6).  
Briefly, this technique is based on the hybridization between the messenger RNA with a small 
modified DNA sequence (like a primer) that targets this mRNA to inhibit the translation of a 
specific gene. For that, four specific ASOs against dotH, dotG, sdhA genes, and also against to 
this gene regulator factor described to L. pneumophila and C. burnetii, PmrA were designed (van 
Schaik E, et al., 2013). For this experiment LF-89 and AUSTRAL-005 strains from P. salmonis 
growing in liquid medium were used. 
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The ASOs were designed to inhibit the translation of the specific genes covering the Shine-
Dalgarno sequence at the ATG from each gene, and the way to prove if the experiment 
worked was by western blot analysis. After bacterial electroporation to get the ASO inside, 
bacteria were incubated for at least 5 days in liquid medium and the total protein was extracted 
to perform western blot analysis. The results showed (fig. 19) that all the samples from LF-89 
strain were inhibited successfully; in the case of AUSTRAL-005 strain the experiment was 
successful for DotH and DotG ASO (fig. 19). Perhaps for the SdhA ASO in the AUSTRAL-
005 strain, the design of the ASO was not very specific and the ASO couldn’t find the mRNA 
target during the time of the experiment. For the DotH and DotG ASO it should be noted 
that those genes have three copies each in the genome, so the design of ASO must be 
correlated with the gene that shows a high level of transcription during in vitro infection. In this 
case, the ASO were directed against different contigs to each DotH and DotG, so probably the 
inhibition by ASO was poor or not completely efficient as was planned. 
Now, it is worthy to note that in the case of PmrA protein, the translation of dotH and dotG 
genes were inhibited in some cases, perhaps because the ASO amount was not optimal. It 
could be the case that by improving the conditions for this experiments one could inhibit 
completely the translation of all the genes involved in the secretion system combining 
electroporation and ASO techniques. 
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 5. CONCLUSIONS 
 
 Genes from Sec-dependent pathway, T4BSS and SdhA effector protein are increased 
during in vitro infection induced by P. salmonis. 
 Proteins from T4BSS DotH and DotG, plus the effector protein SdhA from P. salmonis 
are present during in vitro infection induced by P. salmonis. 
 The ASO technique combined with electroporation represent a possibility to try to 
modify or manipulate the bacteria to study the possible function of certain 
genes/proteins from P. salmonis. 
 All the results obtained in this thesis work proved that the proteins, DotH, DotG and 
SdhA, are important during in vitro infection induced by Piscirickettsia salmonis. 
 With these results, a schematic model for the possible distribution of the T4BSS and 
Sec-dependent pathway in Piscirickettsia salmonis was proposed (figure 20). 
 
6. PERSPECTIVES 
 
Currently little is known about how the pathogen Piscirickettsia salmonis can establish the 
infection in fish and replicate inside the cells. The biggest challenge is to describe possible 
candidate proteins to develop new strategies to avoid the outcome of this disease and diminish 
the mortality induced by Piscirickettsia salmonis. Until now, the good management in salmon 
farming has been controlling the spread of the disease. The wrong and unusual use of 
antibiotics can produce the emergence of resistant bacterial causing this disease that can resist 
the treatment with useful antibiotics, thereby inducing big economic losses to the industry. 
This research contributes to describe the possible ways of how this pathogen can insert 
effector proteins inside the host cell and how it can replicate and survive during the whole 
progression of the disease. With this basic knowledge, we now can try to develop new kind of 
foods with different nutrients and/or small amount of antigens so the fishes can react against 
them to develop a better immunity response. 
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Figure 20: schematic model of the distribution of GSP and T4BSS proteins in P. salmonis with 
the possible substrate using proposed models by: Isberg, et al., 2009; Schulze, et al., 2013; van 
Schaik, et al., 2013. 
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